These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2092466)

  • 1. [Risk assessment in genetic techniques].
    Hobom G
    Verh Dtsch Ges Inn Med; 1990; 96():465-9. PubMed ID: 2092466
    [No Abstract]   [Full Text] [Related]  

  • 2. NATO advanced research workshop report. Recommendations for a scientific approach to safety assurance for environmental introductions of genetically-engineered organisms. Rome, Italy, June 6-10, 1987.
    Recomb DNA Tech Bull; 1987 Dec; 10(4):115-22. PubMed ID: 3481095
    [No Abstract]   [Full Text] [Related]  

  • 3. Containment: comprehensive assessment and integrated control.
    Van Houten J
    J Parenter Sci Technol; 1992; 46(1):22-4. PubMed ID: 1625106
    [No Abstract]   [Full Text] [Related]  

  • 4. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting, February 2, 1987.
    Recomb DNA Tech Bull; 1987 Dec; 10(4):125-57. PubMed ID: 3481096
    [No Abstract]   [Full Text] [Related]  

  • 5. Grafting for transgene containment.
    Lev-Yadun S; Sederoff R
    Nat Biotechnol; 2001 Dec; 19(12):1104. PubMed ID: 11731772
    [No Abstract]   [Full Text] [Related]  

  • 6. Applicability of chemical risk assessment methodologies to risk assessment for genetically engineered microorganisms.
    Dean-Ross D
    Recomb DNA Tech Bull; 1986 Mar; 9(1):16-28. PubMed ID: 3458267
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress of environmental monitoring and biological containment system on genetically engineered microorganisms].
    Li Q; Wu Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Mar; 24(3):355-62. PubMed ID: 18589808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of biological hazards in the biotechnology industry.
    Liberman DF; Israeli E; Fink R
    Occup Med; 1991; 6(2):285-99. PubMed ID: 2047978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems of risk in genetic engineering research].
    Shivtsov OV
    Vestn Akad Med Nauk SSSR; 1981; (2):77-83. PubMed ID: 6941553
    [No Abstract]   [Full Text] [Related]  

  • 10. Change of heart in West German bacterial release debate.
    Dickman S
    Nature; 1988 Mar; 332(6161):198. PubMed ID: 3162294
    [No Abstract]   [Full Text] [Related]  

  • 11. The problems of virus containment.
    Wright AE; Harper GJ; Simpson DI
    Lab Res Methods Biol Med; 1982; 5():305-39. PubMed ID: 7043134
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant DNA hearing at Harvard: nine scientists disagree.
    Pipkin FM
    Boston Univ J; 1976; 24(3):5-21. PubMed ID: 11661367
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stop with all further extension of production using genetic technology].
    Madsen JH
    Sygeplejersken; 1987 Sep; 87(36):30-1. PubMed ID: 3479849
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic engineering. Imperial College fined over hybrid virus risk.
    Pickrell J
    Science; 2001 Aug; 293(5531):779-81. PubMed ID: 11486064
    [No Abstract]   [Full Text] [Related]  

  • 15. Models of genetically engineered organisms and their ecological impact.
    Regal PJ
    Recomb DNA Tech Bull; 1987 Sep; 10(3):67-85. PubMed ID: 3317526
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacterial containment system regulated by the concentration of salicylate].
    Wang H; Ma Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Feb; 24(2):323-7. PubMed ID: 18464620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redesigning man: the dangerous experiment.
    Milton J
    Analog Sci Fict Sci Fact; 1978 Aug; 98(8):44-50+. PubMed ID: 11662518
    [No Abstract]   [Full Text] [Related]  

  • 18. The recombinant DNA debate. [(Title provided[.
    McGarity T
    Univ Kans Law Rev; 1979; 27(3):459-67. PubMed ID: 12083081
    [No Abstract]   [Full Text] [Related]  

  • 19. Legal and regulatory considerations in environmental biotechnology applications.
    McGarity TO
    Recomb DNA Tech Bull; 1985 Mar; 8(1):1-6. PubMed ID: 3858922
    [No Abstract]   [Full Text] [Related]  

  • 20. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Definitions Subcommittee. Minutes of meeting, December 5, 1988.
    Recomb DNA Tech Bull; 1989 Mar; 12(1):3-28. PubMed ID: 2657877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.